cached image

Joel S. Perlmutter, M.D. - Publications

Affiliations: 
Neurology Washington University, Saint Louis, St. Louis, MO 
Area:
movement disorders, Parkinson disease, neuroimaging, dopamine, dystonia, PET
Website:
http://neuro.wustl.edu/aboutus/facultybiographies/perlmutter/

228 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Norris SA, Morris AE, Campbell MC, Karimi M, Babatunde A, Paniello RC, Snyder AZ, Petersen SE, Mink JW, Perlmutter JS. Regional, not global, functional connectivity contributes to isolated focal dystonia. Neurology. PMID 32913023 DOI: 10.1212/Wnl.0000000000010791  0.667
2020 Li H, Knight WC, Yang P, Guo Y, Perlmutter JS, Morris JC, Bateman RJ, Benzinger TLS, Xu J. Microglia Implicated in Tauopathy in the Striatum of Neurodegenerative Disease Patients from Genotype to Phenotype. International Journal of Molecular Sciences. 21. PMID 32842621 DOI: 10.3390/Ijms21176047  0.333
2020 Black KJ, Barton SK, Perlmutter JS. Presymptomatic Testing and Confidentiality in the Age of the Electronic Medical Record. The Journal of Neuropsychiatry and Clinical Neurosciences. appineuropsych200300. PMID 32669021 DOI: 10.1176/Appi.Neuropsych.20030068  0.524
2020 Campbell MC, Myers PS, Weigand AJ, Foster ER, Cairns NJ, Jackson JJ, Lessov-Schlaggar CN, Perlmutter JS. Parkinson disease clinical subtypes: key features & clinical milestones. Annals of Clinical and Translational Neurology. PMID 32602253 DOI: 10.1002/Acn3.51102  0.626
2020 Criswell SR, Nielsen SS, Warden MN, Perlmutter JS, Moerlein SM, Sheppard L, Lenox-Krug J, Checkoway H, Racette BA. [11C]dihydrotetrabenazine Positron Emission Tomography in Manganese-Exposed Workers. Journal of Occupational and Environmental Medicine. PMID 32472844 DOI: 10.1097/Jom.0000000000001915  0.537
2020 Gratton C, Dworetsky A, Coalson RS, Adeyemo B, Laumann TO, Wig GS, Kong TS, Gratton G, Fabiani M, Barch DM, Tranel D, Dominguez OM, Fair DA, Dosenbach NUF, Snyder AZ, ... Perlmutter JS, et al. Removal of high frequency contamination from motion estimates in single-band fMRI saves data without biasing functional connectivity. Neuroimage. 116866. PMID 32325210 DOI: 10.1016/J.Neuroimage.2020.116866  0.533
2020 Mitchell KT, Younce JR, Norris SA, Tabbal SD, Dowling JL, Rich KM, Perlmutter JS, Ushe M. Bilateral Subthalamic Nucleus Deep Brain Stimulation in Elderly Patients With Parkinson Disease: A Case-Control Study. Operative Neurosurgery (Hagerstown, Md.). PMID 32259239 DOI: 10.1093/Ons/Opaa049  0.799
2020 Lungu C, Ozelius L, Standaert D, Hallett M, Sieber BA, Swanson-Fisher C, Berman BD, Calakos N, Moore JC, Perlmutter JS, Pirio Richardson SE, Saunders-Pullman R, Scheinfeldt L, Sharma N, Sillitoe R, et al. Defining research priorities in dystonia. Neurology. PMID 32098856 DOI: 10.1212/Wnl.0000000000009140  0.36
2019 White RL, Campbell MC, Yang D, Shannon W, Snyder AZ, Perlmutter JS. Little Change in Functional Brain Networks Following Acute Levodopa in Drug-Naïve Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31854465 DOI: 10.1002/Mds.27942  0.613
2019 Campbell MC, Jackson JJ, Koller JM, Snyder AZ, Kotzbauer PT, Perlmutter JS. Proteinopathy and longitudinal changes in functional connectivity networks in Parkinson disease. Neurology. PMID 31852813 DOI: 10.1212/Wnl.0000000000008677  0.632
2019 Maiti B, Koller JM, Snyder AZ, Tanenbaum AB, Norris SA, Campbell MC, Perlmutter JS. Cognitive correlates of cerebellar resting-state functional connectivity in Parkinson disease. Neurology. PMID 31848257 DOI: 10.1212/Wnl.0000000000008754  0.615
2019 Yang P, Perlmutter JS, Benzinger TLS, Morris JC, Xu J. Dopamine D3 receptor: a neglected participant in Parkinson Disease pathogenesis and treatment? Ageing Research Reviews. 100994. PMID 31765822 DOI: 10.1016/J.Arr.2019.100994  0.426
2019 Liu H, Luo Z, Gu J, Su Y, Flores H, Parsons SM, Zhou Y, Perlmutter JS, Tu Z. The impact of dopamine D-like agonist/antagonist on [F]VAT PET measurement of VAChT in the brain of nonhuman primates. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 105152. PMID 31740395 DOI: 10.1016/J.Ejps.2019.105152  0.312
2019 Yang D, Deych E, Shands B, Campbell MC, Perlmutter JS, Petersen S, Schlaggar BL, Shannon W. Detecting associations between intact connectomes and clinical covariates using recursive partitioning object-oriented data analysis. Statistics in Medicine. PMID 31650580 DOI: 10.1002/Sim.8374  0.552
2019 Li H, Yang P, Knight W, Guo Y, Perlmutter JS, Tammie BLS, Morris JC, Xu J. The Interactions of Dopamine and Oxidative Damage in the Striatum of Neurodegenerative Diseases Patients. Journal of Neurochemistry. PMID 31613384 DOI: 10.1111/Jnc.14898  0.366
2019 Carlozzi NE, Schilling SG, Boileau NR, Chou KL, Perlmutter JS, Frank S, McCormack MK, Stout JC, Paulsen JS, Lai JS, Dayalu P. How different aspects of motor dysfunction influence day-to-day function in huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31609508 DOI: 10.1002/Mds.27866  0.306
2019 Han F, Perrin RJ, Wang Q, Wang Y, Perlmutter JS, Morris JC, Benzinger TLS, Xu J. Neuroinflammation and Myelin Status in Alzheimer's Disease, Parkinson's Disease, and Normal Aging Brains: A Small Sample Study. Parkinson's Disease. 2019: 7975407. PMID 31354934 DOI: 10.1155/2019/7975407  0.332
2019 Duncan RP, Van Dillen LR, Garbutt JM, Earhart GM, Perlmutter JS. Low Back Pain-Related Disability in Parkinson Disease: Impact on Functional Mobility, Physical Activity, and Quality of Life. Physical Therapy. PMID 31343700 DOI: 10.1093/Ptj/Pzz094  0.322
2019 Rawson KS, McNeely ME, Duncan RP, Pickett KA, Perlmutter JS, Earhart GM. Exercise and Parkinson Disease: Comparing Tango, Treadmill, and Stretching. Journal of Neurologic Physical Therapy : Jnpt. 43: 26-32. PMID 30531383 DOI: 10.1097/Npt.0000000000000245  0.347
2019 Foster E, Morris A, Koller J, Snyder A, Perlmutter J, Campbell M. Cognitive Brain Network Correlates of Everyday Memory in People with Parkinson Disease Archives of Physical Medicine and Rehabilitation. 100: e17-e18. DOI: 10.1016/J.Apmr.2019.08.034  0.585
2018 Younce JR, Campbell MC, Perlmutter JS, Norris SA. Thalamic and ventricular volumes predict motor response to deep brain stimulation for Parkinson's disease. Parkinsonism & Related Disorders. PMID 30527905 DOI: 10.1016/J.Parkreldis.2018.11.026  0.655
2018 Gratton C, Koller JM, Shannon W, Greene DJ, Maiti B, Snyder AZ, Petersen SE, Perlmutter JS, Campbell MC. Emergent Functional Network Effects in Parkinson Disease. Cerebral Cortex (New York, N.Y. : 1991). PMID 30418543 DOI: 10.1093/Cercor/Bhy229  0.718
2018 Junker J, Brandt V, Berman BD, Vidailhet M, Roze E, Weissbach A, Comella C, Malaty IA, Jankovic J, LeDoux MS, Berardelli A, Barbano R, Reich SG, Perlmutter JS, Jinnah HA, et al. Predictors of alcohol responsiveness in dystonia. Neurology. PMID 30341158 DOI: 10.1212/Wnl.0000000000006551  0.318
2018 Milchenko M, Snyder AZ, Campbell MC, Dowling JL, Rich KM, Brier LM, Perlmutter JS, Norris SA. ESM-CT: a precise method for localization of DBS electrodes in CT images. Journal of Neuroscience Methods. PMID 30201271 DOI: 10.1016/J.Jneumeth.2018.09.009  0.589
2018 Gourisankar A, Eisenstein SA, Trapp NT, Koller JM, Campbell MC, Ushe M, Perlmutter JS, Hershey T, Black KJ. Mapping movement, mood, motivation and mentation in the subthalamic nucleus. Royal Society Open Science. 5: 171177. PMID 30109035 DOI: 10.1098/Rsos.171177  0.799
2018 Criswell SR, Warden MN, Searles Nielsen S, Perlmutter JS, Moerlein SM, Sheppard L, Lenox-Krug J, Checkoway H, Racette BA. Selective D2 receptor PET in manganese-exposed workers. Neurology. PMID 30097475 DOI: 10.1212/Wnl.0000000000006163  0.575
2018 Gratton C, Koller JM, Shannon W, Greene DJ, Snyder AZ, Petersen SE, Perlmutter JS, Campbell MC. Emergent Functional Network Effects in Parkinson Disease. Cerebral Cortex (New York, N.Y. : 1991). PMID 29878081 DOI: 10.1093/Cercor/Bhy121  0.746
2018 Duncan RP, Van Dillen LR, Garbutt JM, Earhart GM, Perlmutter JS. Physical therapy and deep brain stimulation in Parkinson's Disease: protocol for a pilot randomized controlled trial. Pilot and Feasibility Studies. 4: 54. PMID 29484198 DOI: 10.1186/S40814-018-0243-2  0.378
2018 Morris AE, Norris SA, Perlmutter JS, Mink JW. Quantitative, clinically relevant acoustic measurements of focal embouchure dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29460980 DOI: 10.1002/Mds.27298  0.5
2018 Milchenko M, Norris SA, Poston K, Campbell MC, Ushe M, Perlmutter JS, Snyder AZ. 7T MRI subthalamic nucleus atlas for use with 3T MRI. Journal of Medical Imaging (Bellingham, Wash.). 5: 015002. PMID 29340288 DOI: 10.1117/1.Jmi.5.1.015002  0.783
2017 Ibanez L, Dube U, Saef B, Budde J, Black K, Medvedeva A, Del-Aguila JL, Davis AA, Perlmutter JS, Harari O, Benitez BA, Cruchaga C. Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels. Bmc Neurology. 17: 198. PMID 29141588 DOI: 10.1186/S12883-017-0978-Z  0.341
2017 Jinnah HA, Comella CL, Perlmutter J, Lungu C, Hallett M. Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy? Toxicon : Official Journal of the International Society On Toxinology. PMID 28888929 DOI: 10.1016/J.Toxicon.2017.09.004  0.36
2017 Criswell SR, Nielsen SS, Warden M, Perlmutter JS, Moerlein SM, Flores HP, Huang J, Sheppard L, Seixas N, Checkoway H, Racette BA. [(18)F]FDOPA Positron Emission Tomography in Manganese-Exposed Workers. Neurotoxicology. PMID 28694016 DOI: 10.1016/J.Neuro.2017.07.004  0.591
2017 Pirio Richardson S, Altenmüller E, Alter K, Alterman RL, Chen R, Frucht S, Furuya S, Jankovic J, Jinnah HA, Kimberley TJ, Lungu C, Perlmutter JS, Prudente CN, Hallett M. Research Priorities in Limb and Task-Specific Dystonias. Frontiers in Neurology. 8: 170. PMID 28515706 DOI: 10.3389/Fneur.2017.00170  0.433
2017 Ibanez L, Dube U, Budde J, Black K, Medvedeva A, Davis AA, Perlmutter JS, Benitez BA, Cruchaga C. TMEM230 in Parkinson's disease. Neurobiology of Aging. PMID 28457580 DOI: 10.1016/J.Neurobiolaging.2017.03.014  0.39
2017 Takeda A, Perlmutter JS. Striatal molecular imaging of presynaptic markers: Ready, fire, aim. Neurology. PMID 28283591 DOI: 10.1212/Wnl.0000000000003827  0.382
2017 Martin WR, Hartlein J, Racette BA, Cairns N, Perlmutter JS. Pathologic correlates of supranuclear gaze palsy with parkinsonism. Parkinsonism & Related Disorders. PMID 28256434 DOI: 10.1016/J.Parkreldis.2017.02.027  0.588
2017 Strafella AP, Bohnen NI, Perlmutter JS, Eidelberg D, Pavese N, Van Eimeren T, Piccini P, Politis M, Thobois S, Ceravolo R, Higuchi M, Kaasinen V, Masellis M, Peralta MC, Obeso I, et al. Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28150432 DOI: 10.1002/Mds.26907  0.346
2017 Lee JK, Ding Y, Conrad AL, Cattaneo E, Epping E, Mathews K, Gonzalez-Alegre P, Cahill L, Magnotta V, Schlaggar BL, Perlmutter JS, Kim RE, Dawson JD, Nopoulos P. Sex-specific effects of the Huntington gene on normal neurodevelopment. Journal of Neuroscience Research. 95: 398-408. PMID 27870408 DOI: 10.1002/Jnr.23980  0.305
2016 Eisenstein SA, Bogdan R, Chen L, Moerlein SM, Black KJ, Perlmutter JS, Hershey T, Barch DM. Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia. Journal of Psychiatric Research. 86: 9-17. PMID 27886638 DOI: 10.1016/J.Jpsychires.2016.11.007  0.775
2016 Peterson DA, Littlewort GC, Bartlett MS, Macerollo A, Perlmutter JS, Jinnah HA, Hallett M, Sejnowski TJ. Objective, computerized video-based rating of blepharospasm severity. Neurology. PMID 27770067 DOI: 10.1212/Wnl.0000000000003336  0.366
2016 Norris SA, Jinnah HA, Espay AJ, Klein C, Brüggemann N, Barbano RL, Malaty IA, Rodriguez RL, Vidailhet M, Roze E, Reich SG, Berman BD, LeDoux MS, Richardson SP, Agarwal P, ... ... Perlmutter JS, et al. Clinical and demographic characteristics related to onset site and spread of cervical dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27753188 DOI: 10.1002/Mds.26817  0.521
2016 Pepino MY, Eisenstein SA, Bischoff AN, Klein S, Moerlein SM, Perlmutter JS, Black KJ, Hershey T. Sweet dopamine: Sucrose preferences relate differentially to striatal D2 receptor binding and age in obesity. Diabetes. PMID 27307220 DOI: 10.2337/Db16-0407  0.772
2016 Eisenstein SA, Bogdan R, Love-Gregory L, Corral-Frías NS, Koller JM, Black KJ, Moerlein SM, Perlmutter JS, Barch DM, Hershey T. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status. Synapse (New York, N.Y.). PMID 27241797 DOI: 10.1002/Syn.21916  0.777
2016 Benitez BA, Davis AA, Jin SC, Ibanez L, Ortega-Cubero S, Pastor P, Choi J, Cooper B, Perlmutter JS, Cruchaga C. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease. Molecular Neurodegeneration. 11: 29. PMID 27094865 DOI: 10.1186/S13024-016-0097-0  0.36
2016 Jin H, Zhang X, Yue X, Liu H, Li J, Yang H, Flores H, Su Y, Parsons SM, Perlmutter JS, Tu Z. Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates. Nuclear Medicine and Biology. 43: 131-9. PMID 26872437 DOI: 10.1016/J.Nucmedbio.2015.11.003  0.375
2016 Eisenstein SA, Gredysa DM, Antenor-Dorsey JA, Green L, Arbeláez AM, Koller JM, Black KJ, Perlmutter JS, Moerlein SM, Hershey T. Correction: Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity. Plos One. 11: e0147063. PMID 26744894 DOI: 10.1371/Journal.Pone.0147063  0.768
2015 Siddiqi SH, Abraham NK, Geiger CL, Karimi M, Perlmutter JS, Black KJ. The Human Experience with Intravenous Levodopa. Frontiers in Pharmacology. 6: 307. PMID 26779024 DOI: 10.3389/Fphar.2015.00307  0.726
2015 Davis AA, Andruska KM, Benitez BA, Racette BA, Perlmutter JS, Cruchaga C. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression. Neurobiology of Aging. PMID 26601739 DOI: 10.1016/J.Neurobiolaging.2015.09.014  0.624
2015 Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, ... ... Perlmutter JS, et al. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. Jama Neurology. 1-9. PMID 26569098 DOI: 10.1001/Jamaneurol.2015.2736  0.547
2015 Buddhala C, Loftin SK, Kuley BM, Cairns NJ, Campbell MC, Perlmutter JS, Kotzbauer PT. Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease. Annals of Clinical and Translational Neurology. 2: 949-59. PMID 26478895 DOI: 10.1002/Acn3.246  0.655
2015 Eisenstein SA, Gredysa DM, Antenor-Dorsey JA, Green L, Arbeláez AM, Koller JM, Black KJ, Perlmutter JS, Moerlein SM, Hershey T. Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity. Plos One. 10: e0133621. PMID 26192187 DOI: 10.1371/Journal.Pone.0133621  0.775
2015 Tian L, Xia Y, Flores HP, Campbell MC, Moerlein SM, Perlmutter JS. Neuroimaging Analysis of the Dopamine Basis for Apathetic Behaviors in an MPTP-Lesioned Primate Model. Plos One. 10: e0132064. PMID 26135399 DOI: 10.1371/Journal.Pone.0132064  0.638
2015 Eisenstein SA, Bischoff AN, Gredysa DM, Antenor-Dorsey JA, Koller JM, Al-Lozi A, Pepino MY, Klein S, Perlmutter JS, Moerlein SM, Black KJ, Hershey T. Emotional Eating Phenotype is Associated with Central Dopamine D2 Receptor Binding Independent of Body Mass Index. Scientific Reports. 5: 11283. PMID 26066863 DOI: 10.1038/Srep11283  0.775
2015 Lucero C, Campbell MC, Flores H, Maiti B, Perlmutter JS, Foster ER. Cognitive reserve and β-amyloid pathology in Parkinson disease. Parkinsonism & Related Disorders. PMID 26037458 DOI: 10.1016/J.Parkreldis.2015.05.020  0.585
2015 Campbell MC, Koller JM, Snyder AZ, Buddhala C, Kotzbauer PT, Perlmutter JS. CSF proteins and resting-state functional connectivity in Parkinson disease. Neurology. 84: 2413-21. PMID 25979701 DOI: 10.1212/Wnl.0000000000001681  0.629
2015 Stewart SB, Koller JM, Campbell MC, Perlmutter JS, Black KJ. Additive global cerebral blood flow normalization in arterial spin labeling perfusion imaging. Peerj. 3: e834. PMID 25802806 DOI: 10.7717/Peerj.834  0.764
2015 Earhart GM, Duncan RP, Huang JL, Perlmutter JS, Pickett KA. Comparing interventions and exploring neural mechanisms of exercise in Parkinson disease: a study protocol for a randomized controlled trial. Bmc Neurology. 15: 9. PMID 25652002 DOI: 10.1186/S12883-015-0261-0  0.317
2015 Buddhala C, Campbell MC, Perlmutter JS, Kotzbauer PT. Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease. Neurobiology of Aging. 36: 476-84. PMID 25212463 DOI: 10.1016/J.Neurobiolaging.2014.07.043  0.633
2014 Dugan LL, Tian L, Quick KL, Hardt JI, Karimi M, Brown C, Loftin S, Flores H, Moerlein SM, Polich J, Tabbal SD, Mink JW, Perlmutter JS. Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates. Annals of Neurology. 76: 393-402. PMID 25043598 DOI: 10.1002/Ana.24220  0.498
2014 Eisenstein SA, Dewispelaere WB, Campbell MC, Lugar HM, Perlmutter JS, Black KJ, Hershey T. Acute changes in mood induced by subthalamic deep brain stimulation in Parkinson disease are modulated by psychiatric diagnosis. Brain Stimulation. 7: 701-8. PMID 25017671 DOI: 10.1016/J.Brs.2014.06.002  0.812
2014 Eisenstein SA, Koller JM, Black KD, Campbell MC, Lugar HM, Ushe M, Tabbal SD, Karimi M, Hershey T, Perlmutter JS, Black KJ. Functional anatomy of subthalamic nucleus stimulation in Parkinson disease. Annals of Neurology. 76: 279-95. PMID 24953991 DOI: 10.1002/Ana.24204  0.8
2014 Vemula SR, Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Truong DD, Blitzer A, Rudzi?ska M, Mom?ilovi? D, et al. A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia. Molecular Genetics & Genomic Medicine. 2: 261-72. PMID 24936516 DOI: 10.1002/Mgg3.67  0.53
2014 Tian L, Karimi M, Brown CA, Loftin SK, Perlmutter JS. In vivo measures of nigrostriatal neuronal response to unilateral MPTP treatment. Brain Research. 1571: 49-60. PMID 24845719 DOI: 10.1016/J.Brainres.2014.05.009  0.301
2014 Semrau JA, Perlmutter JS, Thoroughman KA. Visuomotor adaptation in Parkinson's disease: effects of perturbation type and medication state. Journal of Neurophysiology. 111: 2675-87. PMID 24694937 DOI: 10.1152/Jn.00095.2013  0.351
2014 Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, ... ... Perlmutter JS, et al. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. Jama Neurology. 71: 543-52. PMID 24664227 DOI: 10.1001/Jamaneurol.2014.131  0.355
2014 Peterson DS, Pickett KA, Duncan R, Perlmutter J, Earhart GM. Gait-related brain activity in people with Parkinson disease with freezing of gait. Plos One. 9: e90634. PMID 24595265 DOI: 10.1371/Journal.Pone.0090634  0.33
2014 Black KJ, Snyder AZ, Mink JW, Tolia VN, Revilla FJ, Moerlein SM, Perlmutter JS. Spatial reorganization of putaminal dopamine D2-like receptors in cranial and hand dystonia. Plos One. 9: e88121. PMID 24520350 DOI: 10.1371/Journal.Pone.0088121  0.684
2014 Willis AW, Schootman M, Kung N, Wang XY, Perlmutter JS, Racette BA. Disparities in deep brain stimulation surgery among insured elders with Parkinson disease. Neurology. 82: 163-71. PMID 24336138 DOI: 10.1212/Wnl.0000000000000017  0.617
2014 Peterson DS, Pickett KA, Duncan RP, Perlmutter JS, Earhart GM. Brain activity during complex imagined gait tasks in Parkinson disease. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 125: 995-1005. PMID 24210997 DOI: 10.1016/J.Clinph.2013.10.008  0.397
2014 Armstrong RA, Kotzbauer PT, Perlmutter JS, Campbell MC, Hurth KM, Schmidt RE, Cairns NJ. A quantitative study of α-synuclein pathology in fifteen cases of dementia associated with Parkinson disease. Journal of Neural Transmission (Vienna, Austria : 1996). 121: 171-81. PMID 23996276 DOI: 10.1007/S00702-013-1084-Z  0.588
2014 Black KJ, Snyder AZ, Mink JW, Tolia VN, Revilla FJ, Moerlein SM, Perlmutter JS. Mean location in atlas space of peak [ 18 F]spiperone binding, by group (mm). Plos One. DOI: 10.1371/Journal.Pone.0088121.T001  0.628
2014 Black KJ, Snyder AZ, Mink JW, Tolia VN, Revilla FJ, Moerlein SM, Perlmutter JS. Coronal view of peak [ 18 F]spiperone binding in striatum in cranial and hand dystonia. Plos One. DOI: 10.1371/Journal.Pone.0088121.G002  0.641
2014 Gredysa DM, Eisenstein S, Antenor-Dorsey J, Arbelaez A, Koller J, Black K, Klein S, Perlmutter J, Moerlein S, Agrawal A, Hershey T. Insulin, dopamine D2 receptors, and monetary reward discounting: A common pathway for food and drug addiction Drug and Alcohol Dependence. 140: e73. DOI: 10.1016/J.Drugalcdep.2014.02.219  0.737
2013 Karimi M, Moerlein SM, Videen TO, Su Y, Flores HP, Perlmutter JS. Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia Movement Disorders. 28: 2002-2006. PMID 24151192 DOI: 10.1002/Mds.25720  0.302
2013 Jinnah HA, Berardelli A, Comella C, Defazio G, Delong MR, Factor S, Galpern WR, Hallett M, Ludlow CL, Perlmutter JS, Rosen AR. The focal dystonias: current views and challenges for future research. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 926-43. PMID 23893450 DOI: 10.1002/Mds.25567  0.522
2013 Campbell MC, Markham J, Flores H, Hartlein JM, Goate AM, Cairns NJ, Videen TO, Perlmutter JS. Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases. Neurology. 81: 520-7. PMID 23825179 DOI: 10.1212/Wnl.0B013E31829E6F94  0.62
2013 Sun J, Cairns NJ, Perlmutter JS, Mach RH, Xu J. Regulation of dopamine D₃ receptor in the striatal regions and substantia nigra in diffuse Lewy body disease. Neuroscience. 248: 112-26. PMID 23732230 DOI: 10.1016/J.Neuroscience.2013.05.048  0.345
2013 Brown CA, Karimi MK, Tian L, Flores H, Su Y, Tabbal SD, Loftin SK, Moerlein SM, Perlmutter JS. Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques. Annals of Neurology. 74: 602-10. PMID 23686841 DOI: 10.1002/Ana.23939  0.339
2013 Snyder AZ, Perlmutter JS, Hacker CD. Reply: Levodopa increases functional connectivity in the cerebellum and brainstem in Parkinson's disease Brain. 136: e235. PMID 23650223 DOI: 10.1093/Brain/Awt016  0.311
2013 Eisenstein SA, Antenor-Dorsey JA, Gredysa DM, Koller JM, Bihun EC, Ranck SA, Arbeláez AM, Klein S, Perlmutter JS, Moerlein SM, Black KJ, Hershey T. A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C]methyl)benperidol. Synapse (New York, N.Y.). 67: 748-56. PMID 23650017 DOI: 10.1002/Syn.21680  0.786
2013 Karimi M, Tian L, Brown CA, Flores HP, Loftin SK, Videen TO, Moerlein SM, Perlmutter JS. Validation of nigrostriatal positron emission tomography measures: critical limits. Annals of Neurology. 73: 390-6. PMID 23423933 DOI: 10.1002/Ana.23798  0.325
2013 Ushe M, Perlmutter JS. Sex, drugs and Parkinson's disease. Brain : a Journal of Neurology. 136: 371-3. PMID 23413258 DOI: 10.1093/Brain/Awt022  0.783
2013 Bagchi DP, Yu L, Perlmutter JS, Xu J, Mach RH, Tu Z, Kotzbauer PT. Binding of the Radioligand SIL23 to α-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent Plos One. 8. PMID 23405108 DOI: 10.1371/Journal.Pone.0055031  0.37
2013 Xu J, Vangveravong S, Li S, Fan J, Jones LA, Cui J, Wang R, Tu Z, Chu W, Perlmutter JS, Mach RH. Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist Neuroimage. 71: 168-174. PMID 23333701 DOI: 10.1016/J.Neuroimage.2013.01.007  0.313
2013 Hill KK, Campbell MC, McNeely ME, Karimi M, Ushe M, Tabbal SD, Hershey T, Flores HP, Hartlein JM, Lugar HM, Revilla FJ, Videen TO, Earhart GM, Perlmutter JS. Cerebral blood flow responses to dorsal and ventral STN DBS correlate with gait and balance responses in Parkinson's disease. Experimental Neurology. 241: 105-12. PMID 23262122 DOI: 10.1016/J.Expneurol.2012.12.003  0.797
2013 Harms MB, Neumann D, Benitez BA, Cooper B, Carrell D, Racette BA, Perlmutter JS, Goate A, Cruchaga C. Parkinson disease is not associated with C9ORF72 repeat expansions. Neurobiology of Aging. 34: 1519.e1-2. PMID 23116878 DOI: 10.1016/J.Neurobiolaging.2012.10.001  0.634
2013 Black KJ, Snyder AZ, Tolia VN, Perlmutter JS. A group-averaged structural MRI study of primary focal dystonia F1000research. 4. DOI: 10.7490/F1000Research.1093378.1  0.509
2013 Black KJ, Hershey T, Koller JM, Carl JL, Perlmutter JS. Mapping and quantification of dopamine D2 receptor activation F1000research. 4. DOI: 10.7490/F1000Research.1093169.1  0.669
2013 King AM, Hershey T, Black KJ, Koller JM, Perlmutter JS. Pharmacological activation neuroimaging with levodopa and specific dopamine agonists in primate brain F1000research. 4. DOI: 10.7490/F1000Research.1093157.1  0.693
2013 Perlmutter JS, Snyder AZ, Tolia VN, Revilla F, McGee-Minnich L, Moerlein SM, Black KJ. Does the spatial distribution of putaminal D 2 receptors differ in patients with blepharospasm vs. hand cramp F1000research. 4. DOI: 10.7490/F1000Research.1092988.1  0.529
2013 Black CF, Hartlein JM, Hershey T, Perlmutter JS, Black KJ. A voxel-based morphometry study of Tourette syndrome F1000research. 4. DOI: 10.7490/F1000Research.1092954.1  0.666
2013 Rosen A, Perlmutter J, Comella C, Ludlow C, Hallett M, Galpern W, Ferguson J, Jinnah H. The Dystonia Coalition: Four years of progress Journal of the Neurological Sciences. 333: e132. DOI: 10.1016/J.Jns.2013.07.442  0.349
2012 Ushe M, Perlmutter JS. Oromandibular and lingual dystonia associated with spinocerebellar ataxia type 8. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1741-2. PMID 23283653 DOI: 10.1002/Mds.25295  0.778
2012 Hacker CD, Perlmutter JS, Criswell SR, Ances BM, Snyder AZ. Resting state functional connectivity of the striatum in Parkinson's disease. Brain : a Journal of Neurology. 135: 3699-711. PMID 23195207 DOI: 10.1093/Brain/Aws281  0.402
2012 Willis AW, Schootman M, Tran R, Kung N, Evanoff BA, Perlmutter JS, Racette BA. Neurologist-associated reduction in PD-related hospitalizations and health care expenditures. Neurology. 79: 1774-80. PMID 23054239 DOI: 10.1212/Wnl.0B013E3182703F92  0.61
2012 Racette BA, Criswell SR, Lundin JI, Hobson A, Seixas N, Kotzbauer PT, Evanoff BA, Perlmutter JS, Zhang J, Sheppard L, Checkoway H. Increased risk of parkinsonism associated with welding exposure. Neurotoxicology. 33: 1356-61. PMID 22975422 DOI: 10.1016/J.Neuro.2012.08.011  0.633
2012 Tabbal SD, Tian L, Karimi M, Brown CA, Loftin SK, Perlmutter JS. Low nigrostriatal reserve for motor parkinsonism in nonhuman primates. Experimental Neurology. 237: 355-62. PMID 22836146 DOI: 10.1016/J.Expneurol.2012.07.008  0.365
2012 Kotzbauer PT, Cairns NJ, Campbell MC, Willis AW, Racette BA, Tabbal SD, Perlmutter JS. Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia. Archives of Neurology. 69: 1326-31. PMID 22825369 DOI: 10.1001/Archneurol.2012.1608  0.732
2012 Brown CA, Campbell MC, Karimi M, Tabbal SD, Loftin SK, Tian LL, Moerlein SM, Perlmutter JS. Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys. Experimental Neurology. 236: 190-7. PMID 22579525 DOI: 10.1016/J.Expneurol.2012.04.025  0.639
2012 Eisenstein SA, Koller JM, Piccirillo M, Kim A, Antenor-Dorsey JA, Videen TO, Snyder AZ, Karimi M, Moerlein SM, Black KJ, Perlmutter JS, Hershey T. Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET. Synapse (New York, N.Y.). 66: 770-80. PMID 22535514 DOI: 10.1002/Syn.21566  0.789
2012 Campbell MC, Black KJ, Weaver PM, Lugar HM, Videen TO, Tabbal SD, Karimi M, Perlmutter JS, Hershey T. Mood response to deep brain stimulation of the subthalamic nucleus in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 24: 28-36. PMID 22450611 DOI: 10.1176/Appi.Neuropsych.11030060  0.793
2012 Criswell SR, Perlmutter JS, Huang JL, Golchin N, Flores HP, Hobson A, Aschner M, Erikson KM, Checkoway H, Racette BA. Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders. Occupational and Environmental Medicine. 69: 437-43. PMID 22447645 DOI: 10.1136/Oemed-2011-100119  0.56
2012 Criswell SR, Perlmutter JS, Crippin JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels. Archives of Neurology. 69: 394-7. PMID 22410448 DOI: 10.1001/Archneurol.2011.771  0.601
2012 Tian L, Karimi M, Loftin SK, Brown CA, Xia H, Xu J, Mach RH, Perlmutter JS. No differential regulation of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) binding in a primate model of Parkinson disease. Plos One. 7: e31439. PMID 22359591 DOI: 10.1371/Journal.Pone.0031439  0.331
2012 Willis AW, Schootman M, Kung N, Evanoff BA, Perlmutter JS, Racette BA. Predictors of survival in patients with Parkinson disease. Archives of Neurology. 69: 601-7. PMID 22213411 DOI: 10.1001/Archneurol.2011.2370  0.618
2012 Wright Willis A, Schootman M, Perlmutter J, Racette B. Neurologist Care in PD Is Associated with Fewer PD Related Hospitalizations (P02.242) Neurology. 78: P02.242-P02.242. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P02.242  0.599
2012 Nopoulos P, Epping E, Conrad A, Mathews K, Perlmutter J, Schlaggar B, Paulsen J, Byars J, Magnotta V. G04 Brain structure in children at risk for Huntington's disease Journal of Neurology, Neurosurgery & Psychiatry. 83: A27.2-A27. DOI: 10.1136/Jnnp-2012-303524.84  0.305
2012 Nopoulos P, Mathews K, Paulsen J, Epping E, Conrad A, Perlmutter J, Schlaggar B. I02 Effect of CAG length on motor scores of children at risk for huntington's disease Journal of Neurology, Neurosurgery & Psychiatry. 83: A33.1-A33. DOI: 10.1136/Jnnp-2012-303524.101  0.32
2011 Willis AW, Schootman M, Evanoff BA, Perlmutter JS, Racette BA. Neurologist care in Parkinson disease: A utilization, outcomes, and survival study Neurology. 77: 851-857. PMID 21832214 DOI: 10.1212/Wnl.0B013E31822C9123  0.602
2011 McNeely ME, Hershey T, Campbell MC, Tabbal SD, Karimi M, Hartlein JM, Lugar HM, Revilla FJ, Perlmutter JS, Earhart GM. Effects of deep brain stimulation of dorsal versus ventral subthalamic nucleus regions on gait and balance in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 1250-5. PMID 21478202 DOI: 10.1136/Jnnp.2010.232900  0.748
2011 Criswell SR, Perlmutter JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced uptake of [¹⁸F]FDOPA PET in asymptomatic welders with occupational manganese exposure. Neurology. 76: 1296-301. PMID 21471467 DOI: 10.1212/Wnl.0B013E3182152830  0.6
2011 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, et al. The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 549-52. PMID 21370264 DOI: 10.1002/Mds.23551  0.545
2011 Mach RH, Tu Z, Xu J, Li S, Jones LA, Taylor M, Luedtke RR, Derdeyn CP, Perlmutter JS, Mintun MA. Endogenous dopamine (DA) competes with the binding of a radiolabeled D3 receptor partial agonist in vivo: A positron emission tomography study Synapse. 65: 724-732. PMID 21132811 DOI: 10.1002/Syn.20891  0.324
2011 Criswell SR, Perlmutter JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure Neurology. 76: 1296-1301. DOI: 10.1212/WNL.0b013e3182152830  0.513
2010 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, et al. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Human Genetics. 127: 470. PMID 21488297  0.495
2010 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, et al. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Human Genetics. 127: 469. PMID 21488277  0.495
2010 Foster ER, Campbell MC, Burack MA, Hartlein J, Flores HP, Cairns NJ, Hershey T, Perlmutter JS. Amyloid imaging of Lewy body-associated disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2516-23. PMID 20922808 DOI: 10.1002/Mds.23393  0.705
2010 Hershey T, Campbell MC, Videen TO, Lugar HM, Weaver PM, Hartlein J, Karimi M, Tabbal SD, Perlmutter JS. Mapping Go-No-Go performance within the subthalamic nucleus region. Brain : a Journal of Neurology. 133: 3625-34. PMID 20855421 DOI: 10.1093/Brain/Awq256  0.731
2010 Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, et al. Novel THAP1 sequence variants in primary dystonia. Neurology. 74: 229-38. PMID 20083799 DOI: 10.1212/Wnl.0B013E3181Ca00Ca  0.557
2010 Burack MA, Hartlein J, Flores HP, Taylor-Reinwald L, Perlmutter JS, Cairns NJ. In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology. 74: 77-84. PMID 20038776 DOI: 10.1212/Wnl.0B013E3181C7Da8E  0.313
2009 Simón-Sánchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Krüger R, Federoff M, Klein C, Goate A, Perlmutter J, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nature Genetics. 41: 1308-12. PMID 19915575 DOI: 10.1038/Ng.487  0.608
2009 Racette BA, Good LM, Kissel AM, Criswell SR, Perlmutter JS. A population-based study of parkinsonism in an Amish community. Neuroepidemiology. 33: 225-30. PMID 19641327 DOI: 10.1159/000229776  0.623
2009 Xiao J, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Hedera P, Simon DK, Tarsy D, Truong DD, et al. High-throughput mutational analysis of TOR1A in primary dystonia. Bmc Medical Genetics. 10: 24. PMID 19284587 DOI: 10.1186/1471-2350-10-24  0.547
2009 Earhart GM, Clark BR, Tabbal SD, Perlmutter JS. Gait and balance in essential tremor: Variable effects of bilateral thalamic stimulation Movement Disorders. 24: 386-391. PMID 19006189 DOI: 10.1002/Mds.22356  0.316
2009 Hong M, Perlmutter JS, Earhart GM. A kinematic and electromyographic analysis of turning in people with Parkinson disease Neurorehabilitation and Neural Repair. 23: 166-176. PMID 18981189 DOI: 10.1177/1545968308320639  0.585
2009 Patra B, Parsian AJ, Racette BA, Zhao JH, Perlmutter JS, Parsian A. LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson's disease. Parkinsonism & Related Disorders. 15: 175-80. PMID 18752982 DOI: 10.1016/J.Parkreldis.2008.05.004  0.619
2009 Galvin J, Burke W, Wang J, Racette B, Perlmutter J, Goate A. P3.029 Polymorphisms in aldehyde dehydrogenase and the risk of sporadic Parkinson disease Parkinsonism & Related Disorders. 15: S155. DOI: 10.1016/S1353-8020(09)70593-0  0.578
2008 Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, et al. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. Bmc Medicine. 6: 32. PMID 18986508 DOI: 10.1186/1741-7015-6-32  0.61
2008 Ludlow CL, Adler CH, Berke GS, Bielamowicz SA, Blitzer A, Bressman SB, Hallett M, Jinnah HA, Juergens U, Martin SB, Perlmutter JS, Sapienza C, Singleton A, Tanner CM, Woodson GE. Research priorities in spasmodic dysphonia. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 139: 495-505. PMID 18922334 DOI: 10.1016/J.Otohns.2008.05.624  0.395
2008 Karimi M, Golchin N, Tabbal SD, Hershey T, Videen TO, Wu J, Usche JW, Revilla FJ, Hartlein JM, Wernle AR, Mink JW, Perlmutter JS. Subthalamic nucleus stimulation-induced regional blood flow responses correlate with improvement of motor signs in Parkinson disease. Brain : a Journal of Neurology. 131: 2710-9. PMID 18697909 DOI: 10.1093/Brain/Awn179  0.709
2008 Campbell MC, Karimi M, Weaver PM, Wu J, Perantie DC, Golchin NA, Tabbal SD, Perlmutter JS, Hershey T. Neural correlates of STN DBS-induced cognitive variability in Parkinson disease. Neuropsychologia. 46: 3162-9. PMID 18682259 DOI: 10.1016/J.Neuropsychologia.2008.07.012  0.725
2008 McNicoll CF, Latourelle JC, MacDonald ME, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, et al. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1596-601. PMID 18649400 DOI: 10.1002/Mds.22186  0.626
2008 DeStefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts R, Guttman M, Racette BA, Perlmutter JS, Marlor L, Shill HA, et al. Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Human Genetics. 124: 95-9. PMID 18587682 DOI: 10.1007/S00439-008-0526-4  0.614
2008 Powers WJ, Videen TO, Markham J, Black KJ, Golchin N, Perlmutter JS. Cerebral mitochondrial metabolism in early Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 1754-60. PMID 18575458 DOI: 10.1038/Jcbfm.2008.63  0.588
2008 Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, et al. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology. 71: 28-34. PMID 18509094 DOI: 10.1212/01.Wnl.0000304051.01650.23  0.628
2008 Antenor-Dorsey JAV, Markham J, Moerlein SM, Videen TO, Perlmutter JS. Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans Nuclear Medicine and Biology. 35: 335-341. PMID 18355689 DOI: 10.1016/J.Nucmedbio.2007.12.004  0.306
2008 Tabbal SD, Ushe M, Mink JW, Revilla FJ, Wernle AR, Hong M, Karimi M, Perlmutter JS. Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson disease. Experimental Neurology. 211: 234-42. PMID 18329019 DOI: 10.1016/J.Expneurol.2008.01.024  0.8
2008 Hershey T, Wu J, Weaver PM, Perantie DC, Karimi M, Tabbal SD, Perlmutter JS. Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease. Experimental Neurology. 210: 402-8. PMID 18162183 DOI: 10.1016/J.Expneurol.2007.11.011  0.628
2008 Li Y, Grupe A, Rowland C, Holmans P, Segurado R, Abraham R, Jones L, Catanese J, Ross D, Mayo K, Martinez M, Hollingworth P, Goate A, Cairns NJ, Racette BA, ... Perlmutter JS, et al. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. Human Molecular Genetics. 17: 759-67. PMID 18063669 DOI: 10.1093/Hmg/Ddm348  0.609
2008 Videen TO, Campbell MC, Tabbal SD, Karimi M, Hershey T, Perlmutter JS. Validation of a fiducial-based atlas localization method for deep brain stimulation contacts in the area of the subthalamic nucleus. Journal of Neuroscience Methods. 168: 275-81. PMID 18061273 DOI: 10.1016/J.Jneumeth.2007.10.007  0.724
2008 Foster ER, Black KJ, Antenor-Dorsey JA, Perlmutter JS, Hershey T. Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease. Brain and Cognition. 67: 1-10. PMID 18022303 DOI: 10.1016/J.Bandc.2007.10.002  0.723
2007 Earhart GM, Hong M, Tabbal SD, Perlmutter JS. Effects of thalamic stimulation frequency on intention and postural tremor. Experimental Neurology. 208: 257-63. PMID 17920589 DOI: 10.1016/J.Expneurol.2007.08.014  0.544
2007 Tabbal SD, Revilla FJ, Mink JW, Schneider-Gibson P, Wernle AR, de Erausquin GA, Perlmutter JS, Rich KM, Dowling JL. Safety and efficacy of subthalamic nucleus deep brain stimulation performed with limited intraoperative mapping for treatment of Parkinson's disease. Neurosurgery. 61: 119-27; discussion 1. PMID 17876242 DOI: 10.1227/01.Neu.0000289725.97211.51  0.589
2007 Perlmutter JS, Thach WT. Writer's cramp: questions of causation. Neurology. 69: 331-2. PMID 17646624 DOI: 10.1212/01.Wnl.0000269330.95232.7C  0.642
2007 Powers WJ, Haas RH, Le T, Videen TO, Hershey T, McGee-Minnich L, Perlmutter JS. Normal platelet mitochondrial complex I activity in Huntington's disease. Neurobiology of Disease. 27: 99-101. PMID 17543533 DOI: 10.1016/J.Nbd.2007.04.008  0.539
2007 Hong M, Perlmutter JS, Earhart GM. Enhancement of rigidity in Parkinson's disease with activation. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1164-8. PMID 17443709 DOI: 10.1002/Mds.21524  0.608
2007 Tanner C, Comella C, Kamp C, Kieburtz K, Oakes D, Marshall F, Day D, Carter J, Pahwa R, Shoulson I, Truong D, Tran AH, Thompson K, Shulman LM, Rodriguez D, ... ... Perlmutter J, et al. Pramipexole in levodopa-treated Parkinson disease patients of African, Asian, and Hispanic heritage Clinical Neuropharmacology. 30: 72-85. PMID 17414939 DOI: 10.1097/01.Wnf.0000240943.59617.4C  0.302
2007 Earhart GM, Stevens ES, Perlmutter JS, Hong M. Perception of active and passive turning in Parkinson disease. Neurorehabilitation and Neural Repair. 21: 116-22. PMID 17312086 DOI: 10.1177/1545968306290674  0.608
2007 Powers WJ, Videen TO, Markham J, McGee-Minnich L, Antenor-Dorsey JV, Hershey T, Perlmutter JS. Selective defect of in vivo glycolysis in early Huntington's disease striatum. Proceedings of the National Academy of Sciences of the United States of America. 104: 2945-9. PMID 17299049 DOI: 10.1073/Pnas.0609833104  0.554
2007 Parsian AJ, Racette BA, Zhao JH, Sinha R, Patra B, Perlmutter JS, Parsian A. Association of α-synuclein gene haplotypes with Parkinson's disease Parkinsonism and Related Disorders. 13: 343-347. PMID 17292657 DOI: 10.1016/J.Parkreldis.2006.12.006  0.618
2007 Hong M, Perlmutter JS, Earhart GM. Podokinetic after-rotation in Parkinson disease. Brain Research. 1128: 99-106. PMID 17140549 DOI: 10.1016/J.Brainres.2006.10.053  0.599
2007 Racette BA, Bradley A, Wrisberg CA, Perlmutter JS. Reply from the authors [6] Neurology. 69: 495-496. DOI: 10.1212/01.wnl.0000279165.72261.d0  0.441
2006 Wilk JB, Tobin JE, Suchowersky O, Shill HA, Klein C, Wooten GF, Lew MF, Mark MH, Guttman M, Watts RL, Singer C, Growdon JH, Latourelle JC, Saint-Hilaire MH, DeStefano AL, ... ... Perlmutter JS, et al. Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Neurology. 67: 2206-10. PMID 17190945 DOI: 10.1212/01.Wnl.0000249149.22407.D1  0.601
2006 Racette BA, Bradley A, Wrisberg CA, Perlmutter JS. The impact of litigation on neurologic research. Neurology. 67: 2124-8. PMID 17190932 DOI: 10.1212/01.Wnl.0000249306.85048.86  0.538
2006 Perlmutter JS, Mink JW. Deep brain stimulation. Annual Review of Neuroscience. 29: 229-57. PMID 16776585 DOI: 10.1146/Annurev.Neuro.29.051605.112824  0.596
2006 Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, Parsian A, Guttman M, Nicholson G, Xu G, Wilk JB, et al. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Archives of Neurology. 63: 826-32. PMID 16769863 DOI: 10.1001/Archneur.63.6.826  0.573
2006 Tabbal SD, Mink JW, Antenor JA, Carl JL, Moerlein SM, Perlmutter JS. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine. Neuroscience. 141: 1281-7. PMID 16766129 DOI: 10.1016/J.Neuroscience.2006.04.072  0.52
2006 Ushe M, Mink JW, Tabbal SD, Hong M, Schneider Gibson P, Rich KM, Lyons KE, Pahwa R, Perlmutter JS. Postural tremor suppression is dependent on thalamic stimulation frequency. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1290-2. PMID 16685684 DOI: 10.1002/Mds.20926  0.772
2006 Weiss EM, Hershey T, Karimi M, Racette B, Tabbal SD, Mink JW, Paniello RC, Perlmutter JS. Relative risk of spread of symptoms among the focal onset primary dystonias. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1175-81. PMID 16673404 DOI: 10.1002/Mds.20919  0.725
2006 Racette BA, Good L, Antenor JA, McGee-Minnich L, Moerlein SM, Videen TO, Perlmutter JS. [18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studies. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 141: 245-9. PMID 16528749 DOI: 10.1002/Ajmg.B.30293  0.625
2006 Racette BA, Tabbal SD, Jennings D, Good LM, Perlmutter JS, Evanoff BA. A rapid method for mass screening for parkinsonism. Neurotoxicology. 27: 357-61. PMID 16376428 DOI: 10.1016/J.Neuro.2005.11.005  0.604
2006 Racette BA, Perlmutter JS, Evanoff BA. Reply from the Authors [12] Neurology. 66: 617. DOI: 10.1212/01.Wnl.0000216108.57529.B1  0.496
2006 Hong M, Perlmutter JS, Earhart GM. RECOMMENDATIONS FOR BRADYKINESIA ASSESSMENT IN PARKINSON DISEASE Journal of Neurologic Physical Therapy. 30: 205. DOI: 10.1097/01.Npt.0000281286.38882.9B  0.522
2006 Campbell M, Videen T, Karimi M, Tabbal S, Perlmutter J, Hershey T. IV.P8 Effect of active contact location in STN DBS on spatial working memory performance in Parkinson's Disease (PD) Parkinsonism & Related Disorders. 12: 35. DOI: 10.1016/S1353-8020(07)70117-7  0.724
2006 Foster E, Black K, Antenor J, Moerlein S, Perlmutter J, Hershey T. II.P5 Effects of Parkinson Disease (PD) laterality on spatial working memory performance Parkinsonism & Related Disorders. 12: 26. DOI: 10.1016/S1353-8020(07)70084-6  0.704
2005 Karamohamed S, Latourelle JC, Racette BA, Perlmutter JS, Wooten GF, Lew M, Klein C, Shill H, Golbe LI, Mark MH, Guttman M, Nicholson G, Wilk JB, Saint-Hilaire M, DeStefano AL, et al. BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology. 65: 1823-5. PMID 16344533 DOI: 10.1212/01.Wnl.0000187075.81589.Fd  0.629
2005 Sinha R, Racette B, Perlmutter JS, Parsian A. Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease Parkinsonism and Related Disorders. 11: 341-347. PMID 16019250 DOI: 10.1016/J.Parkreldis.2005.04.003  0.612
2005 Karamohamed S, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, Liu J, Shoemaker CM, Wilk JB, ... ... Perlmutter JS, et al. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1188-91. PMID 15966003 DOI: 10.1002/Mds.20515  0.615
2005 Racette BA, Tabbal SD, Jennings D, Good L, Perlmutter JS, Evanoff B. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders Neurology. 64: 230-235. PMID 15668418 DOI: 10.1212/01.Wnl.0000149511.19487.44  0.606
2005 Racette BA, Antenor JA, McGee-Minnich L, Moerlein SM, Videen TO, Kotagal V, Perlmutter JS. [18F]FDOPA PET and clinical features in parkinsonism due to manganism. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 492-6. PMID 15648057 DOI: 10.1002/Mds.20381  0.612
2005 Black KJ, Hershey T, Hartlein JM, Carl JL, Perlmutter JS. Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson's disease. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 590-601. PMID 15602502 DOI: 10.1038/Sj.Npp.1300632  0.741
2005 Hong M, Earhart G, Damiano D, Perlmutter J. DECREASED ARM SWING AT FAST WALKING SPEED IN MILD PARKINSON DISEASE (PD). Journal of Neurologic Physical Therapy. 29: 209-210. DOI: 10.1097/01.Npt.0000282387.18183.5E  0.563
2004 Racette BA, Esper GJ, Antenor J, Black KJ, Burkey A, Moerlein SM, Videen TO, Kotagal V, Ojemann JG, Perlmutter JS. Pathophysiology of parkinsonism due to hydrocephalus. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 1617-9. PMID 15489399 DOI: 10.1136/Jnnp.2003.028449  0.725
2004 Ushe M, Mink JW, Revilla FJ, Wernle A, Schneider Gibson P, McGee-Minnich L, Hong M, Rich KM, Lyons KE, Pahwa R, Perlmutter JS. Effect of stimulation frequency on tremor suppression in essential tremor. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 1163-8. PMID 15390071 DOI: 10.1002/Mds.20231  0.782
2004 Pastor P, Ezquerra M, Perez JC, Chakraverty S, Norton J, Racette BA, McKeel D, Perlmutter JS, Tolosa E, Goate AM. Novel haplotypes in 17q21 are associated with progressive supranuclear palsy. Annals of Neurology. 56: 249-58. PMID 15293277 DOI: 10.1002/Ana.20178  0.569
2004 Hershey T, Black KJ, Hartlein J, Braver TS, Barch DM, Carl JL, Perlmutter JS. Dopaminergic modulation of response inhibition: an fMRI study. Brain Research. Cognitive Brain Research. 20: 438-48. PMID 15268921 DOI: 10.1016/J.Cogbrainres.2004.03.018  0.702
2004 Black KJ, Koller JM, Snyder AZ, Perlmutter JS. Atlas template images for nonhuman primate neuroimaging: baboon and macaque. Methods in Enzymology. 385: 91-102. PMID 15130735 DOI: 10.1016/S0076-6879(04)85006-7  0.545
2004 Parsian A, Sinha R, Racette B, Zhao JH, Perlmutter JS. Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease Parkinsonism and Related Disorders. 10: 213-219. PMID 15120095 DOI: 10.1016/J.Parkreldis.2003.12.003  0.622
2004 Hershey T, Black KJ, Hartlein JM, Barch DM, Braver TS, Carl JL, Perlmutter JS. Cognitive-pharmacologic functional magnetic resonance imaging in tourette syndrome: a pilot study. Biological Psychiatry. 55: 916-25. PMID 15110735 DOI: 10.1016/J.Biopsych.2004.01.003  0.709
2004 Hershey T, Revilla FJ, Wernle A, Gibson PS, Dowling JL, Perlmutter JS. Stimulation of STN impairs aspects of cognitive control in PD. Neurology. 62: 1110-4. PMID 15079009 DOI: 10.1212/01.Wnl.0000118202.19098.10  0.596
2004 Parsian A, Racette B, Zhang ZH, Rundle M, Perlmutter JS. Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups Genomics. 83: 454-460. PMID 14962671 DOI: 10.1016/J.Ygeno.2003.09.002  0.624
2004 Perlmutter JS, Mink JW. Dysfunction of dopaminergic pathways in dystonia. Advances in Neurology. 94: 163-70. PMID 14509670  0.465
2004 Hong M, Ushe M, Tabbal S, Wernle A, Schneider P, Gibson, Perlmutter JS, Revilla FJ. Differential Effects Of Unilateral Subthalamic Nucleus Stimulation On Motor Symptoms Of Parkinson Disease. Journal of Neurologic Physical Therapy. 28: 174. DOI: 10.1097/01253086-200412000-00020  0.582
2003 Karamohamed S, DeStefano AL, Wilk JB, Shoemaker CM, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, ... ... Perlmutter JS, et al. A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology. 61: 1557-61. PMID 14663042 DOI: 10.1212/01.Wnl.0000095966.99430.F4  0.597
2003 Hershey T, Revilla FJ, Wernle AR, McGee-Minnich L, Antenor JV, Videen TO, Dowling JL, Mink JW, Perlmutter JS. Cortical and subcortical blood flow effects of subthalamic nucleus stimulation in PD. Neurology. 61: 816-21. PMID 14504327 DOI: 10.1212/01.Wnl.0000083991.81859.73  0.688
2003 Racette BA, Good L, Sagitto S, Perlmutter JS. Botulinum toxin B reduces sialorrhea in parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1059-61. PMID 14502678 DOI: 10.1002/Mds.10484  0.579
2003 Bastian AJ, Kelly VE, Perlmutter JS, Mink JW. Effects of pallidotomy and levodopa on walking and reaching movements in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1008-17. PMID 14502668 DOI: 10.1002/Mds.10494  0.589
2003 Bastian AJ, Kelly VE, Revilla FJ, Perlmutter JS, Mink JW. Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1000-7. PMID 14502667 DOI: 10.1002/Mds.10493  0.602
2003 Kaufman JA, Phillips-Conroy JE, Black KJ, Perlmutter JS. Asymmetric regional cerebral blood flow in sedated baboons measured by positron emission tomography (PET). American Journal of Physical Anthropology. 121: 369-77. PMID 12884319 DOI: 10.1002/Ajpa.10181  0.688
2003 Black KJ, Carl JL, Hartlein JM, Warren SL, Hershey T, Perlmutter JS. Rapid intravenous loading of levodopa for human research: clinical results. Journal of Neuroscience Methods. 127: 19-29. PMID 12865145 DOI: 10.1016/S0165-0270(03)00096-7  0.712
2003 Hershey T, Black KJ, Carl JL, McGee-Minnich L, Snyder AZ, Perlmutter JS. Long term treatment and disease severity change brain responses to levodopa in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 844-51. PMID 12810765 DOI: 10.1136/Jnnp.74.7.844  0.741
2002 Black KJ, Hershey T, Koller JM, Videen TO, Mintun MA, Price JL, Perlmutter JS. A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist. Proceedings of the National Academy of Sciences of the United States of America. 99: 17113-8. PMID 12482941 DOI: 10.1073/Pnas.012260599  0.702
2002 Racette BA, Lopate G, Good L, Sagitto S, Perlmutter JS. Ptosis as a remote effect of therapeutic botulinum toxin B injection Neurology. 59: 1445-1447. PMID 12427903 DOI: 10.1212/Wnl.59.9.1445  0.535
2002 Racette BA, Hartlein JM, Hershey T, Mink JW, Perlmutter JS, Black KJ. Clinical features and comorbidity of mood fluctuations in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 14: 438-42. PMID 12426412 DOI: 10.1176/Jnp.14.4.438  0.811
2002 Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Archives of Neurology. 59: 1541-50. PMID 12374491 DOI: 10.1001/Archneur.59.10.1541  0.349
2002 Racette BA, Stambuk M, Perlmutter JS. Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024). Movement Disorders : Official Journal of the Movement Disorder Society. 17: 1098-100. PMID 12360571 DOI: 10.1002/Mds.10209  0.519
2002 Perlmutter JS, Mink JW, Bastian AJ, Zackowski K, Hershey T, Miyawaki E, Koller W, Videen TO. Blood flow responses to deep brain stimulation of thalamus. Neurology. 58: 1388-94. PMID 12011286 DOI: 10.1212/Wnl.58.9.1388  0.689
2002 Racette BA, Rundle M, Wang JC, Goate A, Saccone NL, Farrer M, Lincoln S, Hussey J, Smemo S, Lin J, Suarez B, Parsian A, Perlmutter JS. A multi-incident, Old-Order Amish family with PD. Neurology. 58: 568-74. PMID 11865134 DOI: 10.1212/Wnl.58.4.568  0.626
2002 Parsian A, Racette B, Goldsmith LJ, Perlmutter JS. Parkinson's disease and apolipoprotein E: Possible association with dementia but not age at onset Genomics. 79: 458-461. PMID 11863377 DOI: 10.1006/Geno.2002.6707  0.624
2002 Zackowski KM, Bastian AJ, Hakimian S, Mink JW, Perlmutter JS, Koller WC, Thach WT. Thalamic stimulation reduces essential tremor but not the delayed antagonist muscle timing. Neurology. 58: 402-10. PMID 11839839 DOI: 10.1212/Wnl.58.3.402  0.695
2001 Racette BA, Perry A, D'Avossa G, Perlmutter JS. Late-onset neurodegeneration with brain iron accumulation type 1: Expanding the clinical spectrum Movement Disorders. 16: 1148-1152. PMID 11748751 DOI: 10.1002/Mds.10012  0.569
2001 Black KJ, Koller JM, Snyder AZ, Perlmutter JS. Template images for nonhuman primate neuroimaging: 2. Macaque. Neuroimage. 14: 744-8. PMID 11506546 DOI: 10.1006/Nimg.2001.0871  0.541
2001 Black KJ, Snyder AZ, Koller JM, Gado MH, Perlmutter JS. Template images for nonhuman primate neuroimaging: 1. Baboon. Neuroimage. 14: 736-43. PMID 11506545 DOI: 10.1006/Nimg.2001.0752  0.543
2001 Racette BA, McGee-Minnich L, Moerlein SM, Mink JW, Videen TO, Perlmutter JS. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology. 56: 8-13. PMID 11148228 DOI: 10.1212/Wnl.56.1.8  0.712
2000 Hershey T, Black KJ, Carl JL, Perlmutter JS. Dopa-induced blood flow responses in nonhuman primates. Experimental Neurology. 166: 342-9. PMID 11085899 DOI: 10.1006/Exnr.2000.7522  0.731
2000 Black KJ, Hershey T, Gado MH, Perlmutter JS. Dopamine D(1) agonist activates temporal lobe structures in primates. Journal of Neurophysiology. 84: 549-57. PMID 10899226 DOI: 10.1152/Jn.2000.84.1.549  0.707
1999 Racette BA, McGee-Minnich L, Perlmutter JS. Efficacy and safety of a new bulk toxin of botulinum toxin in cervical dystonia: A blinded evaluation Clinical Neuropharmacology. 22: 337-339. PMID 10626093  0.469
1999 Racette BA, Gokden MS, Tychsen LS, Perlmutter JS. Convergence insufficiency in idiopathic Parkinson's disease responsive to levodopa. Strabismus. 7: 169-74. PMID 10520242 DOI: 10.1076/Stra.7.3.169.636  0.599
1999 Racette BA, Rundle M, Parsian A, Perlmutter JS. Evaluation of a screening questionnaire for genetic studies of Parkinson's disease American Journal of Medical Genetics - Neuropsychiatric Genetics. 88: 539-543. PMID 10490713 DOI: 10.1002/(Sici)1096-8628(19991015)88:5<539::Aid-Ajmg19>3.0.Co;2-S  0.633
1999 Feiwell RJ, Black KJ, McGee-Minnich LA, Snyder AZ, MacLeod AM, Perlmutter JS. Diminished regional cerebral blood flow response to vibration in patients with blepharospasm Neurology. 52: 291-297. PMID 9932946 DOI: 10.1212/Wnl.52.2.291  0.567
1998 Parsian A, Racette B, Zhang ZH, Chakraverty S, Rundle M, Goate A, Perlmutter JS. Mutation, sequence analysis, and association studies of α-synuclein in Parkinson's disease Neurology. 51: 1757-1759. PMID 9855543 DOI: 10.1212/Wnl.51.6.1757  0.592
1998 van Mier H, Tempel LW, Perlmutter JS, Raichle ME, Petersen SE. Changes in brain activity during motor learning measured with PET: effects of hand of performance and practice. Journal of Neurophysiology. 80: 2177-99. PMID 9772270 DOI: 10.1152/Jn.1998.80.4.2177  0.309
1998 Racette BA, Perlmutter JS. Levodopa responsive parkinsonism in an adult with Huntington's disease Journal of Neurology Neurosurgery and Psychiatry. 65: 577-579. PMID 9771791 DOI: 10.1136/Jnnp.65.4.577  0.618
1998 Hershey T, Black KJ, Stambuk MK, Carl JL, McGee-Minnich LA, Perlmutter JS. Altered thalamic response to levodopa in Parkinson's patients with dopa-induced dyskinesias. Proceedings of the National Academy of Sciences of the United States of America. 95: 12016-21. PMID 9751782 DOI: 10.1073/Pnas.95.20.12016  0.748
1998 Black KJ, Ongür D, Perlmutter JS. Putamen volume in idiopathic focal dystonia. Neurology. 51: 819-24. PMID 9748033 DOI: 10.1212/Wnl.51.3.819  0.571
1998 Black KJ, Racette B, Perlmutter JS. Preventing contractions in neuroleptic malignant syndrome and dystonia [2] American Journal of Psychiatry. 155: 1298-1299. PMID 9734560 DOI: 10.1176/Ajp.155.9.1298A  0.644
1998 Racette BA, Lauryssen C, Perlmutter JS. Preoperative treatment with botulinum toxin to facilitate cervical fusion in dystonic cerebral palsy. Report of two cases Journal of Neurosurgery. 88: 328-330. PMID 9452245 DOI: 10.3171/Jns.1998.88.2.0328  0.53
1997 Black KJ, Gado MH, Videen TO, Perlmutter JS. Baboon basal ganglia stereotaxy using internal MRI landmarks: Validation and application to PET imaging Journal of Computer Assisted Tomography. 21: 881-886. PMID 9386276 DOI: 10.1097/00004728-199711000-00006  0.547
1997 Perlmutter JS, Tempel LW, Black KJ, Parkinson D, Todd RD. MPTP induces dystonia and parkinsonism: Clues to the pathophysiology of dystonia Neurology. 49: 1432-1438. PMID 9371934 DOI: 10.1212/Wnl.49.5.1432  0.613
1997 Black KJ, Gado MH, Perlmutter JS. PET measurement of dopamine D2 receptor-mediated changes in striatopallidal function Journal of Neuroscience. 17: 3168-3177. PMID 9096151 DOI: 10.1523/Jneurosci.17-09-03168.1997  0.577
1997 Perlmutter JS, Stambuk MK, Markham J, Black KJ, McGee-Minnich L, Jankovic J, Moerlein SM. Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia Journal of Neuroscience. 17: 843-850. PMID 8987805 DOI: 10.1523/Jneurosci.17-02-00843.1997  0.578
1997 Black KJ, Gado MH, Perlmutter JS. PET Measurement of Dopamine D2Receptor-Mediated Changes in Striatopallidal Function The Journal of Neuroscience. 17: 3168-3177. DOI: 10.1523/JNEUROSCI.17-09-03168.1997  0.509
1997 Perlmutter JS, Stambuk MK, Markham J, Black KJ, McGee-Minnich L, Jankovic J, Moerlein SM. Decreased [18F]Spiperone Binding in Putamen in Idiopathic Focal Dystonia The Journal of Neuroscience. 17: 843-850. DOI: 10.1523/JNEUROSCI.17-02-00843.1997  0.474
1996 Black KJ, Videen TO, Perlmutter JS. A metric for testing the accuracy of cross-modality image registration: Validation and application Journal of Computer Assisted Tomography. 20: 855-861. PMID 8797932 DOI: 10.1097/00004728-199609000-00038  0.542
1996 van Mier H, Perlmutter J, Raichle M, Petersen S. Cortical-cerebellar relationship during continuous motor learning measured by PET Neuroimage. 3: S421. DOI: 10.1016/S1053-8119(96)80423-X  0.312
1992 Powers WJ, Perlmutter JS, Videen TO, Herscovitch P, Griffeth LK, Royal HD, Siegel BA, Morris JC, Berg L. Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease. Neurology. 42: 765-70. PMID 1565229 DOI: 10.1212/Wnl.42.4.765  0.322
1987 Perlmutter JS, Kilbourn MR, Raichle ME, Welch MJ. MPTP-induced up-regulation of in vivo dopaminergic radioligand-receptor binding in humans. Neurology. 37: 1575-9. PMID 3498914 DOI: 10.1212/Wnl.37.10.1575  0.311
Show low-probability matches.